NewsAI-assisted

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification

Marksans Pharma's Goa facility receives EIR from USFDA, inspection classified as VAI.

By Mrudula Kulkarni

Managing Editor - Pharma Now

Aug 21, 2024Updated Jun 26, 2025 · 2 min read

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification — https://www.marksanspharma.com/

AI-assisted reporting

Reviewed by Mrudula Kulkarni, Managing Editor - Pharma Now

For its production site in Verna, Goa, Marksans Pharma said that the USFDA had issued an Establishment Inspection Report (EIR), which it has now successfully closed. According to USFDA findings, this facility's inspection categorisation is Voluntary Action Indicated (VAI).

TopicsNews

Written by

Mrudula Kulkarni

Managing Editor - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.

Discussion

Loading discussion…

Marksans Pharma’s Goa Facility Receives EIR, Inspection Closed with VAI Classification

Discussion

More from Pharma News

Sanofi Appoints Archana Subramanya as Head of R&D India Hub

Kiora Pharmaceuticals Advances KIO-301 Phase 2 Enrollment Toward Coordinated Global Phase 3 Strategy

Emcure Pharma Reports 23% Revenue Rise to Rs 2,580 Crore in Q1 FY2026